|
Mood Effects of Serotonin Agonists: Depression
RECRUITINGEarly 1Sponsored by University of Chicago
Actively Recruiting
PhaseEarly 1
SponsorUniversity of Chicago
Started2025-06-09
Est. completion2026-06-01
Eligibility
Age18 Years – 40 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07017478
Summary
This study will examine the effect of a low dose of the 5HT2A agonist LSD (26 µg), compared to placebo, on acute and protracted mood states in individuals with depression. The investigators will assess the relationship between mood-related symptoms and EEG as a neurophysiological marker.
Eligibility
Age: 18 Years – 40 YearsHealthy volunteers accepted
Inclusion Criteria: * English Fluency * high school education or higher * BMI between 19-30 kg/m2 Exclusion Criteria: * individuals with a medical condition contraindicating study participation as determined by the study physician (e.g., liver disease, abnormal EKG, liver or cardiovascular disease) * high blood pressure (\>140/90) * current suicidal ideation or suicide attempt in past 12 months * past year severe substance use disorder * personal or first-degree relative with history of psychosis * currently taking any psychiatric medication (for conventional antidepressants must be off for ≥ 2 weeks) * active panic disorder * severe obsessive-compulsive disorder * severe post-traumatic stress disorder * women who are pregnant or planning to become pregnant
Conditions3
DepressionLSDMajor Depressive Disorder
Interventions1
Locations1 site
Find trials near these locations
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseEarly 1
SponsorUniversity of Chicago
Started2025-06-09
Est. completion2026-06-01
Eligibility
Age18 Years – 40 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07017478